CODEX DNA INC (DNAY)

US1920031010 - Common Stock

1.3  +0.1 (+8.33%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
6.576M
36.86%		11.043M
67.93%		24.735M
123.99%
EBITDA
YoY % growth
-15.495M
-153.23%		-34.466M
-122.43%		-50.235M
-45.75%
EBIT
YoY % growth
-16.361M
-134.53%		-35.374M
-116.21%		-53.142M
-50.23%
Operating Margin
-248.80%-320.33%-214.85%
EPS
YoY % growth
N/AN/A-1.87

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.47
-9.12%
Revenue
Q2Q % growth		6.426M
108.77%
EBITDA
Q2Q % growth		-12.954M
EBIT
Q2Q % growth		-13.821M
-14.25%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 -0.42
-23.53%		-0.490.0714.22%
Q2 2022
Q2Q % growth		 -0.50
52.83%		-0.530.034.82%
Q1 2022
Q2Q % growth		 -0.45 -0.43-0.02-5.04%
Q4 2021
Q2Q % growth		 -0.43 -0.38-0.05-12.92%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 6.675M
139.59%		5.406M1.269M23.47%
Q2 2022
Q2Q % growth		 5.655M
98.28%		4.539M1.116M24.59%
Q1 2022
Q2Q % growth		 5.636M
142.20%		5.1M536K10.51%
Q4 2021
Q2Q % growth		 3.078M
58.91%		3.91M-832K-21.28%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 0% N/A
Revenue0% N/A 0% N/A